NCT06641440View on ClinicalTrials.gov

Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 30, 2023

Study Completion Date

October 10, 2024

Conditions

Recurrent Pregnancy Loss, Not PregnantRecurrent Implantation Failure

Interventions

DRUG

Prednisone

patients will be treated for three months in the two groups with the two different protocols for three months both

Trial Locations (2)

00153

CERM-Hungaria IVF Center, Rome

Cerm-Hungaria, Rome

All Listed Sponsors

lead

Centre for Endocrinology and Reproductive Medicine, Italy

NETWORK

NCT06641440 - Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test | Biotech Hunter | Biotech Hunter